$IMMU News Article - Immunomedics Announces FDA Acceptance for Filing of Biologics License Application Resubmission for Sacituzumab Govitecan to Treat Metastatic Triple-Negative Breast Cancer
https://marketwirenews.com/news-releases/immu...68962.html